Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Burris

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Pharmacological Reviews|March 5, 2013
Nuclear receptors and their selective pharmacologic modulatorsThomas P Burris, Laura A Solt, Yongjun Wang, et al.
Journal of Medicinal Chemistry|September 6, 2024
Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 ReleaseJoshua M Nicholson, Dexi Yang, Thomas Koelblen, et al.
ACS Chemical Biology|August 26, 2010
Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγYongjun Wang, Naresh Kumar, Philippe Nuhant, et al.
Molecular Genetics and Metabolism|October 7, 2004
T0901317 is a dual LXR/FXR agonistKeith A Houck, Kristen M Borchert, Christopher D Hepler, et al.
The Journal of Biological Chemistry|December 19, 2014
The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2Chun Guo, Yali Li, Chien-Hung Gow, et al.
ACS Chemical Biology|September 8, 2020
A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer CellsEmmalie Schoepke, Cyrielle Billon, Keith M Haynes, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Nature Communications|June 6, 2019
A synthesis strategy for tetracyclic terpenoids leads to agonists of ERβWan Shin Kim, Zachary A Shalit, Sidney M Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regionsPhilip J Rybczynski, Roxanne E Zeck, Donald W Combs, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
SR9009 improves heart function after pressure overload independent of cardiac REV-ERBHui Li, Shiyang Song, Chih-Liang Tien, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Pharmacological Reviews|March 5, 2013
Nuclear receptors and their selective pharmacologic modulatorsThomas P Burris, Laura A Solt, Yongjun Wang, et al.
Journal of Medicinal Chemistry|September 6, 2024
Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 ReleaseJoshua M Nicholson, Dexi Yang, Thomas Koelblen, et al.
ACS Chemical Biology|August 26, 2010
Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγYongjun Wang, Naresh Kumar, Philippe Nuhant, et al.
Molecular Genetics and Metabolism|October 7, 2004
T0901317 is a dual LXR/FXR agonistKeith A Houck, Kristen M Borchert, Christopher D Hepler, et al.
The Journal of Biological Chemistry|December 19, 2014
The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2Chun Guo, Yali Li, Chien-Hung Gow, et al.
ACS Chemical Biology|September 8, 2020
A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer CellsEmmalie Schoepke, Cyrielle Billon, Keith M Haynes, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Nature Communications|June 6, 2019
A synthesis strategy for tetracyclic terpenoids leads to agonists of ERβWan Shin Kim, Zachary A Shalit, Sidney M Nguyen, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Benzoxazinones as PPARgamma agonists. part 1: SAR of three aromatic regionsPhilip J Rybczynski, Roxanne E Zeck, Donald W Combs, et al.
Frontiers in Cardiovascular Medicine|August 1, 2022
SR9009 improves heart function after pressure overload independent of cardiac REV-ERBHui Li, Shiyang Song, Chih-Liang Tien, et al.
Pageof 17